0001551986-19-000047.txt : 20190514 0001551986-19-000047.hdr.sgml : 20190514 20190514141101 ACCESSION NUMBER: 0001551986-19-000047 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190514 DATE AS OF CHANGE: 20190514 EFFECTIVENESS DATE: 20190514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-339562 FILM NUMBER: 19822020 BUSINESS ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 D 1 primary_doc.xml X0708 D LIVE 0001551986 INNOVATE BIOPHARMACEUTICALS, INC. 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC NORTH CAROLINA 27615 919-275-1933 DELAWARE Monster Digital, Inc. Tandon Digital, Inc. Corporation true Sandeep Laumas 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Jay Madan 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Anthony Maida 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Lorin Johnson 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Saira Ramasastry 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Roy Proujansky 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Pharmaceuticals Decline to Disclose 06b false 2019-05-01 false true true false 0 H.C. Wainwright & Co., LLC 375 H.C. Wainwright & Co., LLC 375 430 Park Avenue New York NY NEW YORK 10022 FL FLORIDA NJ NEW JERSEY NY NEW YORK false 8744501 8744501 0 Warrants to purchase up to 4,318,272 shares common, exercise price $2.13, issued to investors in registered equity offering, warrants to purchase up to 215,914 shares of common, exercise price $2.53125, issued to H.C. Wainwright, and underlying shares. false 3 612115 0 Plus management fee, reimbursement of certain expenses, and placement agent warrants. 0 None other than payments of salary in the ordinary course of business. false INNOVATE BIOPHARMACEUTICALS, INC. Jay Madan Jay Madan Chief Business Officer 2019-05-14